Comparison of clinical, tumour-relatedand dosimetric factors in grade 0-1, grade2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours

A. Takeda, Toshio Ohashi, Etsuo Kunieda, N. Sanuki, T. Enomoto, T. Takeda, Y. Oku, Naoyuki Shigematsu

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objective: The aim of this study was to investigate significant clinical, tumour-related and dosimetric factors among patients with grade 0-1, grade 2 and grade 3 radiation pneumonitis (RP) after stereotactic body radiotherapy (SBRT) for lung tumours. Methods: Patients (n=128) with a total of 133 lung tumours treated with SBRT of 50 Gy in 5 fractions were analysed. RP was graded according to the Common Terminology Criteria for Adverse Events v.3.0. Significant factors were identified by univariate and multivariate analyses. Threshold dose-volume histograms (DVHs) were constructed to identify the incidence of RP. Results: The median follow-up period was 12 months (range, 6-45 months). In univariate analyses, gender, operability, forced expiratory volume in 1 s (FEV1), internal target volume, lung volumes treated with doses >5-30 Gy (V5-30) and mean lung dose were significant factors differentiating between grade 0-1 and grade 2 RP, and V15-30 were significant factors differentiating between grade 2 and grade 3. However, no factors were significant between grade 0-1 and grade 3 RP. Multivariate analysis showed that female gender, high FEV1 and high V15 were significant factors differentiating between grade 0-1 and grade 2 RP. Threshold DVH curves were created based on ≤5% and ≤15% risk of grade 2 RP among patients with grade 0-2 RP. Conclusions: Grade 0-2 RP was dose-volume dependent, and female gender and high FEV1 were significant predictive clinical factors for grade 2 RP among patients with grade 0-2 RP. However, incidences of V15-30 in grade 3 RP were significantly lower than those in grade 2 RP, and no significant clinical or tumour-related factors were found. Further studies are needed to identify the mechanism underlying the development of grade 3 RP after SBRT for lung tumours.

Original languageEnglish
Pages (from-to)636-642
Number of pages7
JournalBritish Journal of Radiology
Volume85
Issue number1013
DOIs
Publication statusPublished - 2012 May

Fingerprint

Radiation Pneumonitis
Radiosurgery
Lung
Neoplasms
Forced Expiratory Volume
Multivariate Analysis
Incidence
Terminology

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Comparison of clinical, tumour-relatedand dosimetric factors in grade 0-1, grade2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours. / Takeda, A.; Ohashi, Toshio; Kunieda, Etsuo; Sanuki, N.; Enomoto, T.; Takeda, T.; Oku, Y.; Shigematsu, Naoyuki.

In: British Journal of Radiology, Vol. 85, No. 1013, 05.2012, p. 636-642.

Research output: Contribution to journalArticle

@article{36f1e04cc9c048c1a5a4617c7da72482,
title = "Comparison of clinical, tumour-relatedand dosimetric factors in grade 0-1, grade2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours",
abstract = "Objective: The aim of this study was to investigate significant clinical, tumour-related and dosimetric factors among patients with grade 0-1, grade 2 and grade 3 radiation pneumonitis (RP) after stereotactic body radiotherapy (SBRT) for lung tumours. Methods: Patients (n=128) with a total of 133 lung tumours treated with SBRT of 50 Gy in 5 fractions were analysed. RP was graded according to the Common Terminology Criteria for Adverse Events v.3.0. Significant factors were identified by univariate and multivariate analyses. Threshold dose-volume histograms (DVHs) were constructed to identify the incidence of RP. Results: The median follow-up period was 12 months (range, 6-45 months). In univariate analyses, gender, operability, forced expiratory volume in 1 s (FEV1), internal target volume, lung volumes treated with doses >5-30 Gy (V5-30) and mean lung dose were significant factors differentiating between grade 0-1 and grade 2 RP, and V15-30 were significant factors differentiating between grade 2 and grade 3. However, no factors were significant between grade 0-1 and grade 3 RP. Multivariate analysis showed that female gender, high FEV1 and high V15 were significant factors differentiating between grade 0-1 and grade 2 RP. Threshold DVH curves were created based on ≤5{\%} and ≤15{\%} risk of grade 2 RP among patients with grade 0-2 RP. Conclusions: Grade 0-2 RP was dose-volume dependent, and female gender and high FEV1 were significant predictive clinical factors for grade 2 RP among patients with grade 0-2 RP. However, incidences of V15-30 in grade 3 RP were significantly lower than those in grade 2 RP, and no significant clinical or tumour-related factors were found. Further studies are needed to identify the mechanism underlying the development of grade 3 RP after SBRT for lung tumours.",
author = "A. Takeda and Toshio Ohashi and Etsuo Kunieda and N. Sanuki and T. Enomoto and T. Takeda and Y. Oku and Naoyuki Shigematsu",
year = "2012",
month = "5",
doi = "10.1259/bjr/71635286",
language = "English",
volume = "85",
pages = "636--642",
journal = "British Journal of Radiology",
issn = "0007-1285",
publisher = "British Institute of Radiology",
number = "1013",

}

TY - JOUR

T1 - Comparison of clinical, tumour-relatedand dosimetric factors in grade 0-1, grade2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours

AU - Takeda, A.

AU - Ohashi, Toshio

AU - Kunieda, Etsuo

AU - Sanuki, N.

AU - Enomoto, T.

AU - Takeda, T.

AU - Oku, Y.

AU - Shigematsu, Naoyuki

PY - 2012/5

Y1 - 2012/5

N2 - Objective: The aim of this study was to investigate significant clinical, tumour-related and dosimetric factors among patients with grade 0-1, grade 2 and grade 3 radiation pneumonitis (RP) after stereotactic body radiotherapy (SBRT) for lung tumours. Methods: Patients (n=128) with a total of 133 lung tumours treated with SBRT of 50 Gy in 5 fractions were analysed. RP was graded according to the Common Terminology Criteria for Adverse Events v.3.0. Significant factors were identified by univariate and multivariate analyses. Threshold dose-volume histograms (DVHs) were constructed to identify the incidence of RP. Results: The median follow-up period was 12 months (range, 6-45 months). In univariate analyses, gender, operability, forced expiratory volume in 1 s (FEV1), internal target volume, lung volumes treated with doses >5-30 Gy (V5-30) and mean lung dose were significant factors differentiating between grade 0-1 and grade 2 RP, and V15-30 were significant factors differentiating between grade 2 and grade 3. However, no factors were significant between grade 0-1 and grade 3 RP. Multivariate analysis showed that female gender, high FEV1 and high V15 were significant factors differentiating between grade 0-1 and grade 2 RP. Threshold DVH curves were created based on ≤5% and ≤15% risk of grade 2 RP among patients with grade 0-2 RP. Conclusions: Grade 0-2 RP was dose-volume dependent, and female gender and high FEV1 were significant predictive clinical factors for grade 2 RP among patients with grade 0-2 RP. However, incidences of V15-30 in grade 3 RP were significantly lower than those in grade 2 RP, and no significant clinical or tumour-related factors were found. Further studies are needed to identify the mechanism underlying the development of grade 3 RP after SBRT for lung tumours.

AB - Objective: The aim of this study was to investigate significant clinical, tumour-related and dosimetric factors among patients with grade 0-1, grade 2 and grade 3 radiation pneumonitis (RP) after stereotactic body radiotherapy (SBRT) for lung tumours. Methods: Patients (n=128) with a total of 133 lung tumours treated with SBRT of 50 Gy in 5 fractions were analysed. RP was graded according to the Common Terminology Criteria for Adverse Events v.3.0. Significant factors were identified by univariate and multivariate analyses. Threshold dose-volume histograms (DVHs) were constructed to identify the incidence of RP. Results: The median follow-up period was 12 months (range, 6-45 months). In univariate analyses, gender, operability, forced expiratory volume in 1 s (FEV1), internal target volume, lung volumes treated with doses >5-30 Gy (V5-30) and mean lung dose were significant factors differentiating between grade 0-1 and grade 2 RP, and V15-30 were significant factors differentiating between grade 2 and grade 3. However, no factors were significant between grade 0-1 and grade 3 RP. Multivariate analysis showed that female gender, high FEV1 and high V15 were significant factors differentiating between grade 0-1 and grade 2 RP. Threshold DVH curves were created based on ≤5% and ≤15% risk of grade 2 RP among patients with grade 0-2 RP. Conclusions: Grade 0-2 RP was dose-volume dependent, and female gender and high FEV1 were significant predictive clinical factors for grade 2 RP among patients with grade 0-2 RP. However, incidences of V15-30 in grade 3 RP were significantly lower than those in grade 2 RP, and no significant clinical or tumour-related factors were found. Further studies are needed to identify the mechanism underlying the development of grade 3 RP after SBRT for lung tumours.

UR - http://www.scopus.com/inward/record.url?scp=84860908224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860908224&partnerID=8YFLogxK

U2 - 10.1259/bjr/71635286

DO - 10.1259/bjr/71635286

M3 - Article

C2 - 22253343

AN - SCOPUS:84860908224

VL - 85

SP - 636

EP - 642

JO - British Journal of Radiology

JF - British Journal of Radiology

SN - 0007-1285

IS - 1013

ER -